Patient-specific white blood cell malignancy vaccine regulatory update

BRA subsidiary Biomira USA (Cranbury, N.J.) received U.S. Patent No. 6,207,170 covering an autologous white blood cell membrane-proteoliposome (MPL) vaccine comprised of either cytokines, costimulator...